Drug/Insect/Latex News

Healio compiled the most-read news in allergy, asthma and immunology posted in February.

SAN ANTONIO — A proof-of-concept study showed that de-labeling sailors with reported penicillin allergies can improve operational readiness, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

As COVID-19 has transformed everyday life over the past 3 years, Peter J. Hotez, MD, PhD, DSc, has become a household name.

Sixteen patients at a private dermatology practice in Denmark developed delayed-onset urticaria after receiving COVID-19 vaccine boosters between February and June 2022, according to a letter published in Clinical and Translational Allergy.

Alpha-gal sensitization did not appear prevalent among patients with chronic urticaria, with few patients experiencing clinically relevant alpha-gal allergy, according to a letter published in Clinical and Translational Allergy.

Change is far from incremental in allergy and asthma care based on the speakers and presentations scheduled for the American Academy of Allergy, Asthma & Immunology Annual Meeting in San Antonio from Feb. 24 to 27.

The staff at a pediatric primary care clinic performed direct graded oral challenges for amoxicillin with indirect allergist guidance, according to a study published in Annals of Allergy, Asthma & Immunology.

Healio compiled the most-read news in allergy, asthma and immunology posted in January.

Adolescents aged 12 to 17 years with allergic rhinitis induced by house dust mites now can take a sublingual immunotherapy tablet approved by the FDA after review of multiple trials in this age group.

Patients with negative tests for penicillin allergy following initial reactions should be tested again later for resensitization, particularly when those reactions included anaphylaxis, according to a study published in Allergy.